Menu Search

Company Announcements

Latest announcements

Date and timeCompanyHeadlineSource
INTURAI VENTURES ANNOUNCES CLOSING OF FINAL TRANCHE OF PRIVATE PLACEMENTPR Newswire
INTURAI VENTURES ANNOUNCES CLOSING OF FINAL TRANCHE OF PRIVATE PLACEMENTCanada Newswire
Marcus & Millichap's IPA Capital Markets Arranges $75.1 Million Recapitalization for The Monroe Hotel in Miami Beach's Faena DistrictBusiness Wire
Bloom Energy, Illumina, and Everpure Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600PR Newswire
ETCAMAH® (camizestrant) in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancerBusiness Wire
Guardant Health Announces Landmark FDA Approval of Guardant360® CDx as Companion Diagnostic for AstraZeneca's ETCAMAH™ (camizestrant) in Advanced Breast CancerBusiness Wire
BMO Completes Sale of 138 U.S. Branches to First Citizens BankCanada Newswire
BMO Completes Sale of 138 U.S. Branches to First Citizens BankPR Newswire
Canadian Utilities Receives Alberta Court of Appeal DecisionCanada Newswire
Errington Metals Enters Into Investor Relations AgreementCanada Newswire
Laird Superfood Appoints Mark Johnson as Chief Financial OfficerBusiness Wire
Avanti Helium Closes First Drawdown of US $5 Million with Riverfort Global OpportunitiesCanada Newswire
Actinium Pharmaceuticals, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment ConferencePR Newswire
Royalty Pharma announces update on Novartis’ Phase 3 topline results for pelacarsenGlobeNewswire
Ionis partner Novartis announces Lp(a)HORIZON Phase 3 topline results for pelacarsen in patients with elevated Lp(a) and established cardiovascular disease (CVD)Business Wire
Potomac Edison Proposes Rate Adjustment to Support Electric System ReliabilityPR Newswire
RNS announcements are delayed by up to an hour.
...